Trehalose Neuroprotective Effects on the Substantia Nigra Dopaminergic Cells by Activating Autophagy and Non-canonical Nrf2 Pathways.

Autophagy Non-canonical Nrf2 pathway Parkinson′s disease Trehalose p62

Journal

Iranian journal of pharmaceutical research : IJPR
ISSN: 1735-0328
Titre abrégé: Iran J Pharm Res
Pays: Netherlands
ID NLM: 101208407

Informations de publication

Date de publication:
2019
Historique:
entrez: 10 7 2020
pubmed: 10 7 2020
medline: 10 7 2020
Statut: ppublish

Résumé

Trehalose, as a natural disaccharide, is known as an autophagy inducer. The neuroprotective effects of trehalose in the rat model of Parkinson's disease were the aim of the present study. Parkinson's disease model was induced by injecting 6-hydroxydopamine (6-OHDA) in the striatum of male Wistar rats. Apomorphine-induced behavior and substantia nigra neuronal counts were applied to evaluate the neuroprotective effects of trehalose. The autophagy was studied using the expression of p62 and LC3II/LC3I ratio. In addition, the antioxidant effects of trehalose were assessed by analyzing the levels of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and also glutathione reductase (GR), glutathione peroxidase (GPx) and Catalase (CAT) enzymes. Moreover, the levels of 3, 4-dihydroxyphenylacetic acid (DOPAC) and dopamine (DA) were assessed.The behavioral test showed that trehalose in the treatment group reduced the damage to the substantial nigra dopaminergic neurons, which was characterized by improved motor and reduced rotations in the treatment group as compared with the lesion group. In the histological examinations of the treatment group, trehalose prevented the destruction of dopaminergic neurons. Trehalose treatments increased autophagy (high LC3II/LC3I ratio) and the expression of the p62 protein as well. Through p62-dependent manner, it led to increased nuclear translocation of Nrf2 transcription factor and elevated expression of downstream antioxidant enzymes, such as GR, GPx, and CAT, restoring DA and DOPAC contents of the cells. In the current study, trehalose simultaneously protects substantia nigra dopaminergic cells by activating both non-canonical p62/SQSTM1-Keap1-Nrf2 and autophagy pathways.

Identifiants

pubmed: 32641951
doi: 10.22037/ijpr.2019.2387
pmc: PMC6934986
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1419-1428

Références

Mol Neurobiol. 2017 Apr;54(3):1978-1991
pubmed: 26910814
Iran J Pharm Res. 2018 Winter;17(1):184-192
pubmed: 29755550
Mol Neurobiol. 2016 May;53(4):2258-68
pubmed: 25972237
J Neurol Sci. 2017 Apr 15;375:137-145
pubmed: 28320116
Nat Cell Biol. 2010 Mar;12(3):213-23
pubmed: 20173742
Tissue Cell. 2014 Dec;46(6):462-9
pubmed: 25200619
J Pain. 2010 Jan;11(1):32-43
pubmed: 19632161
Behav Brain Res. 2018 Jul 16;347:26-36
pubmed: 29501508
Neurochem Res. 2016 Apr;41(4):779-86
pubmed: 26537816
Nat Med. 2004 Feb;10(2):148-54
pubmed: 14730359
J Biol Chem. 2007 Feb 23;282(8):5641-52
pubmed: 17182613
J Neuropathol Exp Neurol. 2009 Oct;68(10):1092-102
pubmed: 19918121
Iran J Pharm Res. 2017 Spring;16(2):640-647
pubmed: 28979317
Neuroreport. 2005 May 12;16(7):699-703
pubmed: 15858409
Neurotoxicology. 2014 Sep;44:250-62
pubmed: 25064079
Mol Cell. 2013 Sep 12;51(5):618-31
pubmed: 24011591
Neurosci Lett. 2019 Jun 11;703:86-95
pubmed: 30890473
Iran J Pharm Res. 2015 Winter;14(Suppl):115-20
pubmed: 26185513
Neuroscience. 2018 Jan 15;369:87-96
pubmed: 29138107
CNS Neurol Disord Drug Targets. 2013 Dec;12(8):1114-27
pubmed: 24040813
J Psychopharmacol. 2006 Jan;20(1):67-74
pubmed: 16174681
Behav Brain Res. 2017 May 1;324:71-76
pubmed: 28212940
J Pharmacol Toxicol Methods. 2018 Nov - Dec;94(Pt 1):77-86
pubmed: 29906509
Iran J Pharm Res. 2012 Fall;11(4):1175-81
pubmed: 24250551
Brain Res. 2001 Feb 16;892(1):211-7
pubmed: 11172767
Iran J Pharm Res. 2014 Winter;13(1):227-34
pubmed: 24734075
Iran J Pharm Res. 2013 Winter;12(Suppl):153-9
pubmed: 24250683
Biochem Pharmacol. 1984 Jun 1;33(11):1801-7
pubmed: 6145422
Behav Brain Res. 2019 Jul 23;367:158-165
pubmed: 30905711
J Pharm Pharmacol. 2013 Dec;65(12):1753-6
pubmed: 24236985
Autophagy. 2008 Aug;4(6):770-82
pubmed: 18594198
J Cell Biol. 2011 Apr 18;193(2):275-84
pubmed: 21482715
Bratisl Lek Listy. 2018;119(4):234-239
pubmed: 29663821
Appl Biochem Biotechnol. 2011 Sep;165(2):476-84
pubmed: 21519905
Iran J Pharm Res. 2017 Winter;16(1):140-145
pubmed: 28496469
J Neurochem. 1995 Apr;64(4):1703-7
pubmed: 7891098
J Biol Chem. 2010 Jul 16;285(29):22576-91
pubmed: 20452972
Autophagy. 2014 Apr;10(4):694-6
pubmed: 24447917
Iran J Pharm Res. 2016 Winter;15(1):275-81
pubmed: 27610168
Appl Environ Microbiol. 1995 Oct;61(10):3592-7
pubmed: 7486995
Iran J Pharm Res. 2015 Fall;14(4):1145-52
pubmed: 26664381

Auteurs

Shahram Darabi (S)

Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.

Ali Noori-Zadeh (A)

Department of Clinical Biochemistry, Faculty of Allied Medical Sciences, Ilam University of Medical Sciences, Ilam, Iran.

Hojjat-Allah Abbaszadeh (HA)

Hearing Disorders Research Center, Loghman Hakim Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Anatomical Sciences and Biology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Farzad Rajaei (F)

Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.

Salar Bakhtiyari (S)

Department of Clinical Biochemistry, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.

Classifications MeSH